Scotiabank Raises ADENTRA (TSE:ADEN) Price Target to C$46.00

ADENTRA (TSE:ADENGet Free Report) had its price objective lifted by Scotiabank from C$41.00 to C$46.00 in a research note issued on Thursday,BayStreet.CA reports.

A number of other analysts have also recently weighed in on the stock. CIBC raised their price objective on shares of ADENTRA from C$41.00 to C$42.00 in a report on Tuesday, November 11th. Raymond James Financial increased their target price on shares of ADENTRA from C$43.00 to C$46.00 in a research report on Tuesday, November 11th. Stifel Nicolaus reduced their price target on shares of ADENTRA from C$51.00 to C$45.00 and set a “buy” rating for the company in a research report on Tuesday, October 7th. Finally, National Bankshares upped their price objective on shares of ADENTRA from C$42.50 to C$54.50 and gave the company an “outperform” rating in a research note on Tuesday, October 28th. Five equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

Check Out Our Latest Stock Report on ADEN

ADENTRA Stock Performance

Shares of TSE ADEN opened at $36.20 on Thursday. The stock’s 50-day simple moving average is $34.89 and its 200-day simple moving average is $33.96. The firm has a market capitalization of $876.66 million, a PE ratio of 20.57 and a beta of 1.61. ADENTRA has a fifty-two week low of $24.60 and a fifty-two week high of $39.80.

ADENTRA Company Profile

(Get Free Report)

Adentra Inc is a distributor of architectural products to fabricators, home centers and professional dealers servicing the new residential, repair and remodel, and commercial construction end markets. The company operates a network in North America of 86 facilities in the United States and Canada.

Further Reading

Analyst Recommendations for ADENTRA (TSE:ADEN)

Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.